Trending...
- California: Governor Newsom announces judicial appointments 12.22.2025
- PODS Local Helps Residents Meet Their 2026 New Year's Resolution
- Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
Gold Standard Diagnostics receives FDA clearance for AIX1000® 2.1-- now with extra high titer capabilites.
DAVIS, Calif. - Californer -- Gold Standard Diagnostics Launches AIX1000 2.1® with Extra High Titer RPR Testing and Enhanced Workflow Features
Gold Standard Diagnostics is proud to announce the release of AIX1000® Version 2.1, a major upgrade to its flagship RPR automation platform. This release introduces extra high titer capability, now supporting screens and titers up to 1:2048, a breakthrough in syphilis detection and treatment monitoring—especially for late-stage and Neurosyphilis cases.
The expanded titer range empowers laboratories to more accurately track antibody levels over time, improving clinical decision-making and supporting public health initiatives focused on syphilis control and eradication.
This AIX1000® 2.1 upgrade is the first and only FDA cleared automated test system to meet the 2024 CDC Laboratory Recommendations for Syphilis Testing "Recommendation for endpoint titers. Endpoint titers (the highest dilution yielding a reactive result) should be determined and clearly reported when testing serum with nontreponemal (lipoidal antigen) assays that detect antibodies to lipoidal antigens (i.e., rapid plasma reagin and Venereal Disease Research Laboratory).1"
More on The Californer
"Extra high titer testing is vital for improving detection of late-stage or Neurosyphilis cases, tracking the effectiveness of syphilis treatment over time, and supporting public health need for endpoint titers" said Sean Hoesterey, Vice President of Commercial Operations, at Gold Standard Diagnostics.
In addition to the enhanced titer range, AIX1000® 2.1 delivers a suite of workflow and data management improvements designed to streamline operations and improve clarity:
The AIX1000® 2.1 software is fully compatible with:
Gold Standard Diagnostics was the first FDA cleared automated RPR testing platform in 2015 and continues to lead innovation in automated RPR testing, delivering precision, speed, and reliability to clinical laboratories worldwide.
More on The Californer
For more information, email Gsd.info@us.goldstandarddiagnostics.com or contact your GSD representative.
For media inquiries, please contact:
Sarah Siegel
Marketing Communications Specialist
sarah.siegel@us.goldstandarddiagnostics.com
(707) 239-2863
1Papp J. R. et al. 2024. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep., 73(No. RR-1):1–32. DOI: http://dx.doi.org/10.15585/mmwr.rr7301a1 (https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fdx.doi.org%2F10.15585%2Fmmwr.rr7301a1&data=05%7C02%7C%7C146e2af518cb40e2b79108de0c1bf10a%7C19e5846425f4437da9d21182f30f78eb%7C0%7C0%7C638961511313225122%7CUnknown%7CTWFpbGZsb3d8eyJFbX...).
Gold Standard Diagnostics is proud to announce the release of AIX1000® Version 2.1, a major upgrade to its flagship RPR automation platform. This release introduces extra high titer capability, now supporting screens and titers up to 1:2048, a breakthrough in syphilis detection and treatment monitoring—especially for late-stage and Neurosyphilis cases.
The expanded titer range empowers laboratories to more accurately track antibody levels over time, improving clinical decision-making and supporting public health initiatives focused on syphilis control and eradication.
This AIX1000® 2.1 upgrade is the first and only FDA cleared automated test system to meet the 2024 CDC Laboratory Recommendations for Syphilis Testing "Recommendation for endpoint titers. Endpoint titers (the highest dilution yielding a reactive result) should be determined and clearly reported when testing serum with nontreponemal (lipoidal antigen) assays that detect antibodies to lipoidal antigens (i.e., rapid plasma reagin and Venereal Disease Research Laboratory).1"
More on The Californer
- US Van Rental Expands Group Transportation Services Across Los Angeles
- GIFTAWAY's Wood Wick Candle Collection Sets the Tone for the New Year
- Inclusive Hip-Hop Dance Class with Culture Shock Celebrates Movement Without Limits
- Long Beach: El Dorado Nature Center to Hold New Year, New Use Recycling Drive
- UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
"Extra high titer testing is vital for improving detection of late-stage or Neurosyphilis cases, tracking the effectiveness of syphilis treatment over time, and supporting public health need for endpoint titers" said Sean Hoesterey, Vice President of Commercial Operations, at Gold Standard Diagnostics.
In addition to the enhanced titer range, AIX1000® 2.1 delivers a suite of workflow and data management improvements designed to streamline operations and improve clarity:
- Reflex Runs After Worklist Completion
- Automatic Next Actions
- Improved LIS Communication – Easier for LIS systems to interpret run data
- Enhanced Data Analysis
- Faster Backup and Restore
- Bleach Maintenance Support – Compatible with the GSD Bleach (Cat # SHW-20)
- Optional Text and Email Notifications for Errors
The AIX1000® 2.1 software is fully compatible with:
- Gold Standard Diagnostics Rapid Plasma Reagin (RPR) Test System (Cat # GSD01-1600)
- GSD Bleach (Cat # SHW-20)
- GSD RPR Diluent (Cat # GSD01-1600-DIL)
Gold Standard Diagnostics was the first FDA cleared automated RPR testing platform in 2015 and continues to lead innovation in automated RPR testing, delivering precision, speed, and reliability to clinical laboratories worldwide.
More on The Californer
- "Has Your Book Been Suppressed?" Widespread Censorship by Amazon, Google, and Meta
- TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
- Long Beach Health Department Announces Conclusion of Healthy Active Long Beach Program Following Loss of Federal Funding
- Eric Galuppo Highlights Structural Growth Risk Facing Service Companies
- City of Long Beach Invites Public to Share Their Priorities for the 2027 City Budget at Upcoming Community Meetings
For more information, email Gsd.info@us.goldstandarddiagnostics.com or contact your GSD representative.
For media inquiries, please contact:
Sarah Siegel
Marketing Communications Specialist
sarah.siegel@us.goldstandarddiagnostics.com
(707) 239-2863
1Papp J. R. et al. 2024. CDC Laboratory Recommendations for Syphilis Testing, United States, 2024. MMWR Recomm Rep., 73(No. RR-1):1–32. DOI: http://dx.doi.org/10.15585/mmwr.rr7301a1 (https://nam10.safelinks.protection.outlook.com/?url=http%3A%2F%2Fdx.doi.org%2F10.15585%2Fmmwr.rr7301a1&data=05%7C02%7C%7C146e2af518cb40e2b79108de0c1bf10a%7C19e5846425f4437da9d21182f30f78eb%7C0%7C0%7C638961511313225122%7CUnknown%7CTWFpbGZsb3d8eyJFbX...).
Source: Gold Standard Diagnostics, LLC
Filed Under: Biotech
0 Comments
Latest on The Californer
- City of Long Beach Extends Inclement Weather Action Plans
- Louisa Gillis at North Coast Repertory Theatre
- California: Governor Newsom declares states of emergency related to multiple severe weather events in 2025
- California: Governor Newsom deploys dedicated teams to fight crime in Stockton, building on existing successful partnerships
- BanksyLee.com Is Redefining Daily Financial Insight for the Modern Investor
- California: Governor and LA Rises announce new online resource to further help LA fire survivors navigate rebuilding
- California: Governor Newsom's SAFE Task Force partners with Sacramento to clear encampment
- Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
- Prop 1 brings new projects creating hundreds of housing units for Californians, including veterans
- Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
- Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
- Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
- Governor Newsom mobilizes state resources as California braces for winter storm
- California: Governor Newsom announces judicial appointments 12.22.2025
- Long Beach Mayor Rex Richardson Hosts State of the City Address January 13, 2026
- Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
- Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
- BrassTranscripts Introduces Flat-Rate Pricing with Up to 67% Savings on Long-Form Audio
- Long Beach: City Achieves Housing Milestone: Over 5,000 New Homes Approved
- CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions